Follow
Constantine Dimitrakakis
Constantine Dimitrakakis
Verified email at med.uoa.gr - Homepage
Title
Cited by
Cited by
Year
A physiologic role for testosterone in limiting estrogenic stimulation of the breast
C Dimitrakakis, J Zhou, J Wang, A Belanger, F LaBrie, C Cheng, D Powell, ...
Menopause 10 (4), 292-298, 2003
2402003
Androgens and the breast
C Dimitrakakis, C Bondy
Breast cancer research 11, 1-9, 2009
2062009
Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy
C Dimitrakakis, RA Jones, A Liu, CA Bondy
Menopause 11 (5), 531-535, 2004
1762004
Androgens and mammary growth and neoplasia
C Dimitrakakis, J Zhou, CA Bondy
Fertility and Sterility 77, 26-33, 2002
1272002
Cancer in pregnancy: disentangling treatment modalities
F Zagouri, C Dimitrakakis, S Marinopoulos, A Tsigginou, MA Dimopoulos
ESMO open 1 (3), e000016, 2016
1242016
The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions
C Dimitrakakis, G Kymionis, E Diakomanolis, I Papaspyrou, A Rodolakis, ...
Gynecologic oncology 77 (1), 129-136, 2000
1202000
Breast tuberculosis: Diagnosis, management and treatment
S Marinopoulos, D Lourantou, T Gatzionis, C Dimitrakakis, I Papaspyrou, ...
International journal of surgery case reports 3 (11), 548-550, 2012
1192012
Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS)
R Glaser, AE York, C Dimitrakakis
Maturitas 68 (4), 355-361, 2011
1092011
Testosterone therapy in women: Myths and misconceptions
R Glaser, C Dimitrakakis
Maturitas 74 (3), 230-234, 2013
932013
Taxanes for breast cancer during pregnancy: a systematic review
F Zagouri, TN Sergentanis, D Chrysikos, C Dimitrakakis, A Tsigginou, ...
Clinical Breast Cancer 13 (1), 16-23, 2013
922013
High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer
F Zagouri, Z Bago-Horvath, F Rössler, A Brandstetter, R Bartsch, ...
British journal of cancer 108 (5), 1100-1105, 2013
892013
Testosterone and breast cancer prevention
R Glaser, C Dimitrakakis
Maturitas 82 (3), 291-295, 2015
752015
Reduced breast cancer incidence in women treated with subcutaneous testosterone, or testosterone with anastrozole: a prospective, observational study
RL Glaser, C Dimitrakakis
Maturitas 76 (4), 342-349, 2013
722013
Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients?
GD Kymionis, CE Dimitrakakis, MM Konstadoulakis, I Arzimanoglou, ...
Journal of Surgical Research 99 (2), 161-168, 2001
702001
Testosterone pellet implants and migraine headaches: a pilot study
R Glaser, C Dimitrakakis, N Trimble, V Martin
Maturitas 71 (4), 385-388, 2012
612012
Soy isoflavones and breast cancer risk: a meta-analysis
I Boutas, A Kontogeorgi, C Dimitrakakis, SN Kalantaridou
in vivo 36 (2), 556-562, 2022
602022
Absence of transplacental passage of the low molecular weight heparin enoxaparin
C Dimitrakakis, P Papageorgiou, I Papageorgiou, A Antzaklis, ...
Pathophysiology of Haemostasis and Thrombosis 30 (5), 243-248, 2000
562000
Challenges in managing breast cancer during pregnancy
F Zagouri, T Psaltopoulou, C Dimitrakakis, R Bartsch, MA Dimopoulos
Journal of thoracic disease 5 (Suppl 1), S62, 2013
542013
The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30
OM Ginsburg, MR Akbari, Z Aziz, R Young, H Lynch, P Ghadirian, ...
Familial cancer 8, 563-567, 2009
482009
Allelic imbalance in selected chromosomal regions in ovarian cancer
LL Hansen, LL Jensen, C Dimitrakakis, S Michalas, F Gilbert, HRK Barber, ...
Cancer genetics and cytogenetics 139 (1), 1-8, 2002
482002
The system can't perform the operation now. Try again later.
Articles 1–20